We therefore hypothesize that this high IGF1+IGF2/IGFBP3 molar ratio, resulting in high total (IGF1+IGF2) bioavailability, could slow down the evolution form HS to fibrosis or cirrhosis. The gene discussed is IGFBP3; the disease is Cirrhosis.